KCNN4 and breast neoplasm: Notably, the abundance of KCa3.1 in the breast tumor has been associated with enhanced treatment efficacy and sensitivity to cisplatin [14], presumably via the contribution of KCa3.1 to the cellular uptake of cisplatin [15].